Regenerative Medicine and Stem Cells Technologies

A major hurdle to using neural stem cells derived from genetically different donors to replace damaged or destroyed tissues, such as in a spinal cord injury, has been the persistent rejection of the introduced material (cells), necessitating the use of complex drugs and techniques to suppress the host’s immune response.

The potentially fatal condition affects 30 million Americans, most of whom dont realize they have chronic kidney disease. No cure exists, and current treatments for end-stage disease mostly are limited to dialysis and kidney transplant.

The University of Kansas Medical Center announced that the U.S. Food and Drug Administration (FDA) has cleared it to begin a first-in-human clinical trial of MSCTC-0010 in patients with de novo high-risk acute or steroid-refractory acute graft-versus-host disease (HR/SR aGvHD).

Chinese researchers have used a gene-editing technique to repair a defect in a human embryo, moving biomedicine one step closer to a cure for inheritable diseases caused by genetic mutations, scientists said.

Harvard University researchers have bioengineered a three-dimensional model of a human left heart ventricle that could be used to study diseases, test drugs and develop patient-specific treatments for heart conditions such as arrhythmia.

Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumour work together to infiltrate the brain, and this finding could ultimately lead to much needed new treatments, according to a new study published in Nature Medicine today.

What if cancer cells could be re-engineered to turn against their own kind? A new study led by researchers at Brigham and Womens Hospital leverages the power of gene editing to take a critical step toward using cancer cells to kill cancer.

Biotech company 10x Genomics, which helps analyze the human biological code to understand and improve health, is one of the best-funded enterprises in Silicon Valley at the intersection of biology and technology.

Gene therapy has gained momentum in the past year, following the federal government’s approval of the first such treatments for inherited retinal diseases and hard-to-treat leukemia.

According to the public relations and information center of the Vice-Presidency for science and technology affairs, Sorena Sattari, the vice president for science and technology affairs, met with Hojjatoleslam Seyed Mohammad Ali Al Hashem, the Friday Imam of Tabriz and representative of Imam Khamenei in East Azerbaijan Province, during which he stated: this province has a significant capacity of creative and educated human resources. In this regard, provision of a proper business environment can lay the foundation for knowledge-based businesses.